News

Biomarkers for progression and repair in MS: the key to developing treatments for progressive forms of MS

10 December 2013

Related News

27 August 2025

CEO Rohan Greenland details the upcoming handover of the Blueprint for a National Action Plan for Neurological Conditions, a prod…

26 August 2025

A new Australian study shows COVID-19 boosters improve protection against new variants for people with MS, even when taking immune-suppressing…
Read More
needle

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

Biomarkers for progression and repair in MS: the key to developing treatments for progressive forms of MS